Dosing of adults with early Alzheimer’s disease in clinical trial expected H2 2026 - LEXINGTON, Mass., June 01, 2026 (GLOBE ...

Voyager Technologies, Inc. is a Strong Buy: $67 target on Starlab, Artemis/CLPS & Golden Dome catalysts, rising backlog, and ...

LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...

Voyager Technologies (NYSE:VOYG) has signed an agreement to acquire Astrobotic Technology, a Pittsburgh-based company focused on commercial lunar delivery, surface power systems, and reusable ...

Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.

'We realize that Voyager means a lot to people and we are doing our best to keep them going for as long as possible.' By Andrew Paul Published Dec 14, 2023 11:35 AM EST Add Popular Science (opens in a ...

Voyager intends to accelerate investment to scale Astrobotic’s programs, including lunar and reusable rocket programs.

For nearly five decades, NASA's twin Voyager probes have plumbed the cosmos in search of answers to some of astronomy's most perplexing mysteries about our solar system and its place in the wider ...

- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...